Enter to open, tab to navigate, enter to select
Pernix Therapeutics Holdings, Inc. acquisition of certain assets of GlaxoSmithKline plc
| May 13, 2014 • Private Acquisition Agreements • $250 million (subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.